Vice President, Equity Research
Jack Crowley’s equity research focus is on the agriculture, tourism, and financial sectors.
Since joining Jarden in 2015, he’s provided insights on a number of investment banking transactions, including co-authoring IPO research on AFT Pharmaceuticals, Tegel Group Holdings Limited, and New Zealand King Salmon Ltd.
Jack enjoys the challenge of keeping pace with evolving markets. He has an MBus (Finance, with Distinction) and a BCom (Finance) from the University of Otago, and has passed all three levels of the CFA Program. Jack grew up on a lifestyle block near Taupo and enjoys spending time with his family, mountain biking and surfing.